Skip to main content
SpringerLink
Log in

Clinical aspects and epidemiology of hepatitis B and C viruses in hepatocellular carcinoma in Japan

  • Plenary Session: State of the Art in Liver Cancer
  • HBV, HCV Hepatocellular Carcinoma
  • Published:
Cancer Chemotherapy and Pharmacology Aims and scope Submit manuscript

Summary

The incidence of hepatocellular carcinoma (HCC) in Japan has increased over the past two decades. Of the 379 patients with HCC treated at Shinshu University Hospital over the past 20 years, 112 underwent treatment between 1971 and 1980 and 267 were treated between 1981 and 1990. The prevalence of hepatitis B virus-associated HCC and hepatitis C virus-associated HCC was 54% and 34%, respectively, during the first decade and 31% and 60%, respectively, during the second decade. Major factors contributing to the increased incidence of HCC include an increase in the incidence of type C chronic hepatitis and an increase in the incidence of cirrhosis of the liver, which in turn are the result of blood transfusions received about 30 years ago. Donated blood testing positive for hepatitis C virus antibody is currently rejected from the blood supply. However, the occurrence of posttransfusion hepatitis with the potential to develop into HCC has not been entirely eliminated. In addition, there is an as yet unelucidated route of horizontal transmission of hepatitis C virus.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Beasley RP (1982) Hepatitis B virus as the etiologic agent in hepatocellular carcinoma — epidemiologic considerations. Hepatology 2:21 S

    Google Scholar 

  2. Chisari FV, Klopchin K, Moriyama T, Pasquinelli C, Dunsford HA, Sell S, Pinkert CA, Brinster RL, Palmiter RD (1989) Molecular pathogenesis of hepatocellular carcinoma in hepatitis B virus transgenic mice. Cell 59:1145

    Google Scholar 

  3. Choo Q-L, Kuo G, Weiner AJ, Overby LR, Bradley DW, Houghton M (1989) Isolation of a cDNA clone derived from a blood-borne non-A, non-B vira hepatitis genome. Science 244:359

    Google Scholar 

  4. Colombo M, Kuo G, Choo Q-L, Donato MF, Del Ninno E, Tommasini MA, Dioguardi N, Houghton M (1989) Prevalence of antibodies to hepatitis C virus in Italian patients with hepatocellular carcinoma. Lancet II:1006

    Google Scholar 

  5. Dienstag JL (1983) Non-A, non-B hepatitis: I. Recognition, epidemiology, and clinical features. Gastroenterology 85:439

    Google Scholar 

  6. Esteban JI, Esteban R, Viladomiu L, López-Talavera JC, González A, Hernández JM, Roget M, Vargas V, Genescà J, Buti M, Guardia J, Houghton M, Choo Q-L, Kuo G (1989) Hepatitis C virus antibodies among risk groups in Spain. Lancet II:294

    Google Scholar 

  7. Everhart JE, Di Bisceglie AM, Murray LM, Alter HJ, Melpolder JJ, Kuo G, Hoofnagle JH (1990) Risk for non-A, non-B (type C) hepatitis through sexual or household contact with chronic carriers. Ann Intern Med 112:544

    Google Scholar 

  8. Franca ST, Kiyosawa K, Imai Y, Sodeyama T, Hayata T, Nakano Y, Nakamura M, Furuta S (1989) Change of intrahepatic expression of hepatitis-B core antigen during the clinical course of type-B chronic hepatitis. Scand J Gastroenterol 24:454

    Google Scholar 

  9. Gilliam JH, Geisinger KR, Richter JE (1984) Primary hepatocellular carcinoma after chronic non-A, non-B posttransfusion hepatitis. Ann Intern Med 101:794

    Google Scholar 

  10. Katayama T, Kikuchi S, Tanaka Y, Saito I, Miyamura T, Choo Q-L, Houghton M, Kuo G (1990) Blood screening for non-A, non-B hepatitis by hepatitis C virus antibody assay. Transfusion 30:374

    Google Scholar 

  11. Kiyosawa K, Akahane Y, Nagata A, Koike Y, Furuta S (1982) The significance of blood transfusion in non-A, non-B chronic liver disease in Japan. Vox Sang 43:45

    Google Scholar 

  12. Kiyosawa K, Akahane Y, Nagata A, Furuta S (1984) Hepatocellular carcinoma after non-A, non-B posttransfusion hepatitis. Am J Gastroenterol 79:777

    Google Scholar 

  13. Kiyosawa K, Yamamura N, Sodeyama T, Yoda H, Imai Y, Imai H, Franca SMT, Furuta S (1988) Intrahepatic expression of HBsAg and HBcAg in asymptomatic HBsAg carriers and its follow-up. J Gastroenterol Hepatol 3:19

    Google Scholar 

  14. Kiyosawa K, Sodeyama T, Tanaka E, Gibo Y, Yoshizawa K, Nakano Y, Furuta S, Akahane Y, Nishioka K, Purcell RH, Alter HJ (1990) Interrelationship of blood transfusion, non-A, non-B hepatitis and hepatocellular carcinoma: analysis by detection of antibody to hepatitis C virus. Hepatology 12:671

    Google Scholar 

  15. Kiyosawa K, Sodeyama T, Tanaka E, Shimizu S, Furuta S, Miyazaki Y, Akahane Y, Suzuki H (1991) Intrafamilial transmission of hepatitis C virus in Japan. J Med Virol 33:114

    Google Scholar 

  16. Kuo G, Choo Q-L, Alter HJ, Gitnick GL, Redeker AG, Purcell RH, Miyamura T, Dienstag JL, Alter MJ, Stevens CE, Tegtmeier GE, Bonino F, Colombo M, Lee W-S, Kuo C, Berger K, Shuster JR, Overby LR, Bradley DW, Houghton M (1989) An assay for circulating antibodies to a major etiologic virus of human non-A, non-B hepatitis. Science 244:362

    Google Scholar 

  17. London WT, Blumberg BS (1982) A cellular model of the role of hepatitis B virus in pathogenesis of primary hepatocellular carcinoma. Hepatology 2:10S

    Google Scholar 

  18. Moriarty AM, Alexander H, Lerner RA, Thornton GB (1985) Antibodies to peptides detect new hepatitis B antigen: serological correlation with hepatocellular carcinoma. Science 227:429

    Google Scholar 

  19. Nishioka K, Watanabe J, Furuta S, Tanake E, Iino S, Suzuki H, Tsuji T, Yano M, Kuo G, Choo Q-L, Houghton M, Oda T, (1991) A high prevalence of antibody to the hepatitis C virus in patients with hepatocellular carcinoma in Japan. Cancer 67:429

    Google Scholar 

  20. Okuda K, Fujimoto I, Hanai A, Urano Y (1987) Changing incidence of hepatocellular carcinoma in Japan. Cancer Res 47:4967

    Google Scholar 

  21. Poel CL van der, Reesink HW, Schaasberg W, Leentvaar-Kuypers A, Bakker E, Exel-Oehlers PJ, Lelie PN (1990) Infectivity of blood seropositive for hepatitis C virus antibodies. Lancet 335:558

    Google Scholar 

  22. Resnick RH, Stone K, Antonioli D (1983) Primary hepatocellular carcinoma following non-A, non-B posttransfusion hepatitis. Dig Dis Sci 28:908

    Google Scholar 

  23. Takada S, Koike K (1990) Trans-activation function of a 3′ truncated X gene-cell fusion product from integrated hepatitis B virus DNA in chronic hepatitis tissues. Proc Natl Acad Sci USA 87:5623

    Google Scholar 

  24. Takada S, Koike K (1990) X protein of hepatitis B virus resembles a serine protease inhibitor. Jpn J Cancer Res 81:1191

    Google Scholar 

  25. Watanabe J, Minegishi K, Mitsumori T, Ishifuji M, Oguchi T, Ueda M, Tokunaga E, Tanaka E, Kiyosawa K, Furuta S, Katayama T, Kuo G, Choo Q-L, Houghton M, Nishioka K (1990) Prevalence of anti-HCV antibody in blood donors in the Tokyo area. Vox Sang 59:86

    Google Scholar 

  26. Yu MC, Tong MJ, Coursaget P, Ross RK, Govindarajan S, Henderson BE (1990) Prevalence of hepatitis B and C viral markers in black and white patients with hepatocellular carcinoma in the United States. J Natl Cancer Inst 82:1038

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. The Second Department of Internal Medicine, Shinshu University School of Medicine, 3-1-1, Asahi, 390, Matsumoto, Nagano-Ken, Japan

    Kendo Kiyosawa & Seiichi Furuta

Authors
  1. Kendo Kiyosawa
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Seiichi Furuta
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Kiyosawa, K., Furuta, S. Clinical aspects and epidemiology of hepatitis B and C viruses in hepatocellular carcinoma in Japan. Cancer Chemother. Pharmacol. 31 (Suppl 1), S150–S156 (1992). https://doi.org/10.1007/BF00687126

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF00687126

Keywords

Search

Navigation